These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2021929)

  • 21. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes of glycolipids dependent on cell density of Ehrlich ascites carcinoma cells.
    Prokazova NV; Kocharov SL; Shaposhnikova GI; Zvezdina ND; Bergelson LD
    Eur J Biochem; 1984 Jun; 141(3):527-9. PubMed ID: 6745256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells.
    Greeder GA; Milner JA
    Science; 1980 Aug; 209(4458):825-7. PubMed ID: 7406957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing effect of hydrocortisone acetate administration on the content of A-type particles in Ehrlich ascites tumor.
    Kodama T; Kodama M; Nishi Y
    J Natl Cancer Inst; 1984 Jul; 73(1):227-31. PubMed ID: 6588227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
    Terlikowski S; Nowak HF
    Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth dependent changes of glycolipid compositions of mouse ascites tumor cells.
    Egawa K; Choi YS; Tanino T
    Jpn J Exp Med; 1975 Jun; 45(3):155-9. PubMed ID: 1177358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gossypol inhibits Ehrlich ascites tumor cell proliferation.
    Tso WW
    Cancer Lett; 1984 Oct; 24(3):257-61. PubMed ID: 6498805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
    Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
    Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
    Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
    J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on antitumor effects in tumor bearing mice fed the vitamin A deficient diet (author's transl)].
    Shiwaku Y
    Igaku Kenkyu; 1979 Apr; 49(1):1-46. PubMed ID: 517063
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
    Terlikowski S; Sulkowska M; Nowak HF
    J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation and modulation of Ehrlich ascites tumor growth with tumor-plasma IgA.
    Ghosh AK; Saha S
    Indian J Exp Biol; 2000 Apr; 38(4):313-22. PubMed ID: 11218806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the rates of lipogenesis and hepatic triglyceride secretion in mice bearing Ehrlich ascites carcinoma.
    Bálint Z; Szikla K; Holczinger L
    In Vivo; 1989; 3(2):129-33. PubMed ID: 2519840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caffeine inhibits the development of Ehrlich ascites carcinoma cells in female mice.
    Mukhopadhyay S; Poddarr MK
    Indian J Exp Biol; 2001 Aug; 39(8):735-41. PubMed ID: 12018573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation on glutamine amidohydrolase (EC 3.5.1.2) and glutamine aminotransferase (EC 2.5.1.15) activity in liver and plasma of EAC-bearing mice following glutaminase therapy.
    Pal S; Maity P
    Cancer Lett; 1992 Oct; 66(3):225-31. PubMed ID: 1451103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice.
    El-Azab M; Hishe H; Moustafa Y; El-Awady el-S
    Eur J Pharmacol; 2011 Feb; 652(1-3):7-14. PubMed ID: 21114990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological activity of diospyrin towards Ehrlich ascites carcinoma in Swiss A mice.
    Hazra B; Sur P; Roy DK; Sur B; Banerjee A
    Planta Med; 1984 Aug; 50(4):295-7. PubMed ID: 6505078
    [No Abstract]   [Full Text] [Related]  

  • 38. Antitumorigenic potential of diallyl sulfide in Ehrlich ascites tumor bearing mice.
    Shukla Y; Arora A; Singh A
    Biomed Environ Sci; 2002 Mar; 15(1):41-7. PubMed ID: 12046547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aegle marmelos (L.) Correa inhibits the proliferation of transplanted Ehrlich ascites carcinoma in mice.
    Jagetia GC; Venkatesh P; Baliga MS
    Biol Pharm Bull; 2005 Jan; 28(1):58-64. PubMed ID: 15635164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor Properties of Modified Detonation Nanodiamonds and Sorbed Doxorubicin on the Model of Ehrlich Ascites Carcinoma.
    Medvedeva NN; Zhukov EL; Inzhevatkin EV; Bezzabotnov VE
    Bull Exp Biol Med; 2016 Jan; 160(3):372-5. PubMed ID: 26742746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.